TNF inhibition represents a promising immunomodulatory approach for COVID-19 treatment [28,29], given its potential to mitigate inflammation, particularly the pro-inflammatory cytokines associated with adverse outcomes in COVID-19 patients [30]. Here, TNF is linked to COVID-19.